A team of distinguished scientists lead Micregen’s research and pre-clinical development.
They have published hundreds of peer-reviewed papers over the last thirty years. Their research, gaining insights into degenerative mechanisms in numerous diseases, has been published in journals including The New England Journal of Medicine, Nature, The British Medical Journal and The Lancet. In addition, their research has helped gradually uncover how stem cell secretions influence disease and degeneration.
The team has a combined experience of over one hundred years in stem cell research and is at the forefront of research in the field of stem cell secretome.
Steve Ray, PhD
Chief Scientist
A former Senior Lecturer in Acute & Emergency Care at Oxford Brookes University, Professor of Neuroscience at the Carrick Institute Florida, served as International Scientific Advisor to major South African and Swiss stem cell clinics and cell banks.
Steve has extensive experience in the clinical application of stem cell secretomes that extends over twenty-eight years. He has presented over one hundred papers at international scientific conferences, with nineteen as the keynote speaker. He has already translated his research through to proven clinical practice.
KETAN PATEL, PhD
Director of Research
Professor of Regenerative Medicine & Head of Molecular and Cellular Medicine at the University of Reading, Adjunct Professor at Eppendorf University Clinic, Germany. Ketan has over twenty-eight years research experience working on stem cells with the key aim of utilising stem cells to treat human diseases.
He has pioneered work in the field of muscular dystrophy and identified key proteins that control cell fate process, i.e., when a stem cell makes the decision of whether to remain as a stem cell or to embark on a tissue repair programme. Identifying the mechanisms supporting muscle development and muscle stem cell migration, key properties in mediating tissue repair. Ketan has developed novel procedures to generate cell-free reagents that show unprecedented tissue repair properties.
Paolo De Coppi, MD PhD
Senior Consultant
Professor Paolo De Coppi is a Consultant Paediatric Surgeon at Great Ormond Street Hospital and Reader and Head of Stem Cells and Regenerative Medicine at the University College London Institute of Child Health.
He has been an Honorary Professor at the Katholieke Universiteit Leuven, Belgium, since 2013, an Adjunct Assistant Professor for Regenerative Medicine, Wake Forest University in Winston-Salem, North Carolina, since 2009 and an Honorary Assistant Professor in Paediatric Surgery at the University of Padua, Italy, since 2005.
Paolo is a founder of Micregen and leading the transition of Micregen’s first product through clinical trials.
Robert Mitchell, PhD
Head of Development
Rob obtained his PhD at the University of Reading with his thesis specialising on the regenerative capabilities of the adult stem cell secretome, with a particular emphasis on its effect on skeletal muscle. Rob has worked with Steve and Ketan for over twelve years.
Prior to working towards his PhD, Rob worked for a leading life sciences company, developing and manufacturing a wide range of reagents from their constituent materials. Since 2019 Rob has managed and coordinated Micregen’s clinical manufacturing programme, preparing Micregen’s first therapeutic to enter a combined phase I/II clinical trial in the UK.